74 related articles for article (PubMed ID: 2421296)
1. Polyclonal antibody directed against 2-5A-dependent RNase.
Dieffenbach CW; Krause D; Silverman RH
Prog Clin Biol Res; 1985; 202():105-14. PubMed ID: 2421296
[No Abstract] [Full Text] [Related]
2. The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
Meurs E; Krause D; Robert N; Silverman RH; Hovanessian AG
Prog Clin Biol Res; 1985; 202():307-15. PubMed ID: 2421309
[No Abstract] [Full Text] [Related]
3. Cell viability and the (2',5')oligo(A)-RNase L pathway in human colon carcinoma cells treated with human interferons and double-stranded RNA.
Chapekar MS; Glazer RI
Prog Clin Biol Res; 1985; 202():377-84. PubMed ID: 2421317
[No Abstract] [Full Text] [Related]
4. Role of degradation products of 2-5A in the localized cleavage of viral RNA.
Baglioni C; Williams GJ
Prog Clin Biol Res; 1985; 202():275-83. PubMed ID: 3832073
[No Abstract] [Full Text] [Related]
5. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
Kushner DM; Paranjape JM; Bandyopadhyay B; Cramer H; Leaman DW; Kennedy AW; Silverman RH; Cowell JK
Gynecol Oncol; 2000 Feb; 76(2):183-92. PubMed ID: 10637068
[TBL] [Abstract][Full Text] [Related]
6. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
Williams GJ; De Benedetti A; Baglioni C
Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
[TBL] [Abstract][Full Text] [Related]
8. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
9. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
[TBL] [Abstract][Full Text] [Related]
10. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
J Biol Chem; 1995 Jun; 270(22):13308-17. PubMed ID: 7539425
[TBL] [Abstract][Full Text] [Related]
12. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
[TBL] [Abstract][Full Text] [Related]
13. RNase L, a (2'-5')-oligoadenylate-dependent endoribonuclease: assays and purification of the enzyme; cross-linking to a (2'-5')-oligoadenylate derivative.
Floyd-Smith G; Lengyel P
Methods Enzymol; 1986; 119():489-99. PubMed ID: 2429152
[No Abstract] [Full Text] [Related]
14. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the (2'-5') oligoadenylate system by characterization of cells deficient in their response to interferon.
Panet A; Arad G; Rappoport S; Hochman Y
Prog Clin Biol Res; 1985; 202():345-50. PubMed ID: 2421313
[No Abstract] [Full Text] [Related]
16. 3'-Fluoro-3'-deoxy analogs of 2-5A 5'-monophosphate: binding to 2-5A-dependent endoribonuclease and susceptibility to (2'-5')phosphodiesterase degradation.
Kalinichenko EN; Podkopaeva TL; Kelve M; Saarma M; Mikhailopulo IA
Biochem Biophys Res Commun; 1990 Feb; 167(1):20-6. PubMed ID: 2155612
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide structural features involved in binding to and activation of the 2-5A-dependent endoribonuclease of L cells.
Imai J; Lesiak K; Johnston MI; Torrence PF
Nucleic Acids Symp Ser; 1982; (11):97-100. PubMed ID: 7183979
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal antibodies against RNase L. Subcellular localization of this enzyme in mouse cells.
Salehzada T; Silhol M; Lebleu B; Bisbal C
J Biol Chem; 1991 Mar; 266(9):5808-13. PubMed ID: 1706339
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of action of interferon.
Baglioni C; Nilsen TW; Maroney PA; de Ferra F
Tex Rep Biol Med; 1981-1982; 41():471-8. PubMed ID: 6189211
[No Abstract] [Full Text] [Related]
20. The 2-5A system and vaccinia virus.
Esteban M; Paez E
Prog Clin Biol Res; 1985; 202():25-34. PubMed ID: 2421306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
